Format

Send to

Choose Destination
See comment in PubMed Commons below
BMC Med. 2012 Oct 4;10:116. doi: 10.1186/1741-7015-10-116.

Personalized medicine in multiple sclerosis: hope or reality?

Author information

  • 1Department of Neurology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland. TDerfuss@uhbs.ch

Abstract

Personalized treatment is highly desirable in multiple sclerosis because it is an immensely heterogeneous disease. This heterogeneity is seen in both the disease course and the treatment responses. Currently, a combination of clinical features and imaging parameters in magnetic resonance imaging is used to classify active and non-active patients and treatment responders and non-responders. Although this classification works on a group level, individual patients often behave differently from the group. Therefore additional biomarkers are needed to provide better indicators for prognosis and treatment response. Basic and clinical research have discovered different promising targets. It is now essential to verify the utility and accuracy of these markers in large, prospectively sampled patient cohorts.

[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Write to the Help Desk